Osseotite
Payments companies reported to CMS as associated with Osseotite. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Osseotite, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Osseotite
These are the largest totals companies reported as associated with Osseotite. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Charles Lawrie | Miami, FL | Orthopaedic Surgery | $12,000.00 |
| Adolph Lombardi | New Albany, OH | Adult Reconstructive Orthopaedic Surgery | $11,750.00 |
| Ian Weber | Westminster, CO | Orthopaedic Surgery | $5,131.67 |
| Keith Fehring | Charlotte, NC | Orthopaedic Surgery | $1,000.00 |
| Jess Lonner | Bryn Mawr, PA | Orthopaedic Surgery | $875.00 |
| Andrew Freiberg | Boston, MA | Orthopaedic Surgery | $800.00 |
| Charles Decook | Cumming, GA | Orthopaedic Surgery | $387.50 |
| Harry Schmaltz | Dickson City, PA | Orthopaedic Surgery | $250.00 |
| Brian Maurer | Peoria, IL | Orthopaedic Surgery | $215.25 |
| Rishi Chatterji | Boca Raton, FL | Orthopaedic Surgery | $182.33 |
Prescribed Osseotite?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.